NCT00001561View on ClinicalTrials.gov

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 1996

Study Completion Date

September 30, 2005

Conditions
Graft vs Host DiseaseMultiple Myeloma
Interventions
DRUG

Myeloma Immunoglobulin Idiotype Vaccine-KLH

DRUG

GM-CSF

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH